proxyvotesnow.com

Home › Asset managers › UBS › 2025-2026 › Against the board

UBS 2025-2026: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal UBS voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

2,366 proposals.

UBS, 2025-2026 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedUBS votedFunds
Bruker Corporation May 21, 2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Burford Capital Ltd. May 13, 2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement for the 2026 annual general meeting of shareholders under "Executive compensation", including the compensation discussion and analysis, the compensation tables and the related narrative discussion included therein ("Say-on-Pay"). Say-on-Pay Board (inferred) AGAINST 3
Byline Bancorp, Inc. June 2, 2026 TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT. Say-on-Pay Board (inferred) AGAINST 3
C3.ai, Inc. October 3, 2025 Advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
CAVA Group, Inc. June 22, 2026 Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
CBIZ, Inc. May 14, 2026 To approve, on an advisory basis, the named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
CBL & Associates Properties, Inc. May 21, 2026 An advisory vote on the approval of executive compensation. Say-on-Pay Board (inferred) AGAINST 3
CEVA, Inc. June 2, 2026 Advisory vote to approve named executive officer compensation Say-on-Pay Board (inferred) AGAINST 3
CF Industries Holdings, Inc. April 28, 2026 Election of Directors: John W. Eaves Director Elections Board AGAINST 3
CG Oncology, Inc. June 4, 2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
CNO Financial Group, Inc. May 12, 2026 Approval, by non-binding advisory vote, of the executive compensation of the Company's Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
CNX Resources Corporation May 7, 2026 Advisory Approval of CNX's Named Executive Officer Compensation. Say-on-Pay Board (inferred) AGAINST 3
CONMED Corporation May 18, 2026 Advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
CRA International, Inc. July 17, 2025 To approve, on an advisory basis, the compensation paid to CRA's named executive officers, as disclosed in the proxy statement for the 2025 meeting of its shareholders. Say-on-Pay Board (inferred) AGAINST 3
CRISPR Therapeutics AG June 4, 2026 Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay Board (inferred) AGAINST 3
CSG Systems International, Inc. January 30, 2026 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to named executive officers of CSG in connection with the consummation of the merger; and Say-on-Pay Board (inferred) AGAINST 3
CTS Corporation May 14, 2026 Approval, on an advisory basis, of the compensation of CTS' named executive officers. Say-on-Pay Board (inferred) AGAINST 3
CVB Financial Corp. May 20, 2026 To approve, on a non-binding advisory basis, the compensation of CVB Financial Corp.'s named executive officers ("Say-On-Pay") Say-on-Pay Board (inferred) AGAINST 3
CVR Energy, Inc. June 4, 2026 To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Cabot Corporation March 12, 2026 To approve, in an advisory vote, Cabot's executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Cactus, Inc. May 12, 2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as reported in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Calix, Inc. May 14, 2026 To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Camden National Corporation May 19, 2026 To approve, by non-binding advisory vote, the compensation of the Company's named executive officers ("Say on Pay"). Say-on-Pay Board (inferred) AGAINST 3
Camping World Holdings, Inc. May 21, 2026 Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Cannae Holdings, Inc. December 12, 2025 Approval, on an advisory (non-binding) basis, of the 2024 compensation paid to the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Capital City Bank Group, Inc. April 21, 2026 To consider and approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Capitol Federal Financial, Inc. January 27, 2026 Advisory vote on executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Capricor Therapeutics, Inc. June 4, 2026 APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS Say-on-Pay Board (inferred) AGAINST 3
CarGurus, Inc. June 3, 2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025. Say-on-Pay Board (inferred) AGAINST 3
CareDx, Inc. June 11, 2026 Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Carpenter Technology Corporation October 7, 2025 Approve the compensation of the corporation's named executive officers, in an advisory vote. Say-on-Pay Board (inferred) AGAINST 3
Carter's, Inc. May 13, 2026 Advisory approval of compensation of our named executive officers Say-on-Pay Board (inferred) AGAINST 3
Casella Waste Systems, Inc. June 4, 2026 To approve, in an advisory "say-on-pay" vote, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Castle Biosciences, Inc. May 28, 2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Cathay General Bancorp May 18, 2026 Approval, on a non-binding advisory basis, of the compensation paid to Cathay General Bancorp's named executive officers as disclosed in the proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Cavco Industries, Inc. July 29, 2025 Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay Board (inferred) AGAINST 3
Celcuity Inc. May 14, 2026 To approve, on an advisory basis, named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Celldex Therapeutics, Inc. June 25, 2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Central Garden & Pet Company February 11, 2026 To approve an advisory vote on the compensation of the Company's named executive officers as described in the accompanying proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Central Pacific Financial Corp. April 30, 2026 To approve, on a non-binding advisory basis, the compensation of the company's named executive officers ("Say-On-Pay"). Say-on-Pay Board (inferred) AGAINST 3
Centrus Energy Corp. June 18, 2026 To hold an advisory vote to approve the Company's executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Centuri Holdings, Inc. May 19, 2026 Approval, on a non-binding, advisory basis, of executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Century Aluminum Company June 15, 2026 Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Century Communities, Inc. May 6, 2026 To approve, on an advisory basis, our executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Champion Homes, Inc. July 24, 2025 To consider a non-binding advisory vote on fiscal 2025 compensation paid to Champion Homes, Inc.'s Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
Chart Industries, Inc. October 6, 2025 To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay Board (inferred) AGAINST 3
Chemed Corporation May 18, 2026 Advisory vote to approve executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Chewy, Inc. July 10, 2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Choice Hotels International, Inc. May 21, 2026 Advisory approval of the compensation of the Company's Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
Chord Energy Corporation April 29, 2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Chubb Limited May 21, 2026 Election of the Board of Directors: David H. Sidwell Director Elections Board AGAINST 3
Cimpress plc December 17, 2025 Approve, on a non-binding, advisory basis, the compensation of Cimpress' named executive officers, as described in the company's proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Cipher Digital Inc. June 2, 2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Cirrus Logic, Inc. July 29, 2025 Advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
City Holding Company April 29, 2026 Proposal to approve a non-binding advisory proposal on the compensation of the Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
Clean Harbors, Inc. May 20, 2026 To approve on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Company's definitive proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Clear Channel Outdoor Holdings, Inc. May 12, 2026 A proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company's named executive officers in connection with the Merger (the "Advisory Compensation Proposal"). Say-on-Pay Board (inferred) AGAINST 3
Clear Secure, Inc. June 10, 2026 Approval of, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Clearwater Analytics Holdings, Inc. May 6, 2026 To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. Say-on-Pay Board (inferred) AGAINST 3
Coca-Cola Consolidated, Inc. May 12, 2026 Approval, on an advisory basis, of Coca-Cola Consolidated's named executive officer compensation in fiscal 2025. Say-on-Pay Board (inferred) AGAINST 3
Cogent Biosciences, Inc. June 9, 2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Cognex Corporation April 29, 2026 To approve, on an advisory basis, the compensation of Cognex's named executive officers, as described in the proxy statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion ("say-on-pay"). Say-on-Pay Board (inferred) AGAINST 3
Cohen & Steers, Inc. April 30, 2026 Approval, by non-binding advisory vote, of the compensation of the company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Coherent Corp. November 13, 2025 Non-binding advisory vote to approve compensation paid to named executive officers in fiscal year 2025. Say-on-Pay Board (inferred) AGAINST 3
Cohu, Inc. May 15, 2026 Advisory vote to approve our Named Executive Officer compensation, or "Say-on-Pay." Say-on-Pay Board (inferred) AGAINST 3
Collegium Pharmaceutical, Inc. May 14, 2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay Board (inferred) AGAINST 3
Columbia Banking System, Inc. May 14, 2026 To approve, on an advisory basis, the compensation of Columbia Banking System, Inc.'s named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Comerica Incorporated January 6, 2026 Proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Comerica's named executive officers in connection with the first merger. Say-on-Pay Board (inferred) AGAINST 3
Commerce Bancshares, Inc. April 24, 2026 Advisory approval of the Company's executive compensation ("Say on Pay"). Say-on-Pay Board (inferred) AGAINST 3
Community Financial System, Inc. May 20, 2026 Advisory vote on executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Community Trust Bancorp, Inc. April 28, 2026 Proposal to approve the advisory (nonbinding) resolution relating to executive compensation. Say-on-Pay Board (inferred) AGAINST 3
Compass Minerals International, Inc. March 5, 2026 Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Compass, Inc. May 14, 2026 Advisory Vote to Approve 2025 Named Executive Officer Compensation ("Say-on-Pay Vote") Say-on-Pay Board (inferred) AGAINST 3
Concentra Group Holdings Parent, Inc. April 30, 2026 Hold a non-binding advisory vote on the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
ConnectOne Bancorp, Inc. May 19, 2026 To vote, on an advisory basis, to approve the executive compensation of ConnectOne Bancorp, Inc.'s named executive officers, as described in the proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Corcept Therapeutics Incorporated May 21, 2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Core Laboratories Inc. May 12, 2026 To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables. Say-on-Pay Board (inferred) AGAINST 3
Core Natural Resources, Inc. April 30, 2026 Approval, on an Advisory Basis, of the Compensation Paid to Core Natural Resources, Inc.'s Named Executive Officers in 2025. Say-on-Pay Board (inferred) AGAINST 3
Core Scientific, Inc. October 30, 2025 Core Scientific's Advisory Compensation Proposal Say-on-Pay Board (inferred) AGAINST 3
Core Scientific, Inc. May 12, 2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
CoreCivic, Inc. May 14, 2026 Advisory vote to approve the compensation of our Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 3
Coty Inc. November 6, 2025 Approval, on an advisory (non-binding) basis, of the compensation of Coty Inc.'s named executive officers, as disclosed in the proxy statement Say-on-Pay Board (inferred) AGAINST 3
Coupang, Inc. June 11, 2026 To consider a non-binding vote to approve the compensation of Coupang, Inc.'s named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Coursera, Inc. June 10, 2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Crane Company April 27, 2026 Say on Pay - An advisory vote to approve the compensation paid to certain executive officers. Say-on-Pay Board (inferred) AGAINST 3
Crane NXT, Co. May 21, 2026 Say on Pay - An advisory vote to approve the compensation paid by the Company to its named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Credit Acceptance Corporation June 10, 2026 Advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Credo Technology Group Holding Ltd October 13, 2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay Board (inferred) AGAINST 3
Cricut, Inc. June 3, 2026 To approve, by non-binding vote, named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Crinetics Pharmaceuticals, Inc. June 18, 2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and Say-on-Pay Board (inferred) AGAINST 3
Crocs, Inc. June 9, 2026 An advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
Crown Holdings, Inc. April 30, 2026 Approval by advisory vote of the resolution on executive compensation as described in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
Cullen/Frost Bankers, Inc. April 29, 2026 To provide nonbinding approval of executive compensation; Say-on-Pay Board (inferred) AGAINST 3
Cullinan Therapeutics, Inc. June 16, 2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Cushman & Wakefield Ltd. May 14, 2026 Non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed in the Proxy Statement ("Say-on-Pay"). Say-on-Pay Board (inferred) AGAINST 3
Customers Bancorp, Inc. May 26, 2026 To approve a non-binding advisory resolution on named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 3
Cytokinetics, Incorporated May 27, 2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 3
DENTSPLY SIRONA Inc. June 2, 2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. Say-on-Pay Board (inferred) AGAINST 3
DNOW Inc. May 20, 2026 To consider and act upon an advisory proposal to approve the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 3
DT Midstream, Inc. May 5, 2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers; and Say-on-Pay Board (inferred) AGAINST 3

← Previous Page 6 of 24 Next →

← Back to UBS 2025-2026 overview

Built November 1, 2026 from SEC Form N-PX filings.